In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: The current price of $11.48 is 22.7% below the PERT-weighted fair value of $14.08, indicating potential undervaluation. However, poor financial health (1.20/5 score) and negative DCF values suggest significant operational challenges. The zero downside risk from Monte Carlo analysis contrasts with high analyst target prices, highlighting divergent valuation signals.